SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AVR - Avitar
AVR 5.590+3.3%Dec 26 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
To: Andrew Ross who started this subject11/6/2000 4:34:05 PM
From: Andrew Ross   of 5
 
Staffing Resources Inc. Uses Avitar Inc.'s ORALscreen(TM) to Pre-Qualify its Workforce
PR Newswire - November 06, 2000 10:59

CANTON, Mass., Nov. 6 /PRNewswire/ -- Avitar, Inc. (Amex: AVR) announced today that its client, Staffing Resources, Inc. of Matteson, IL, has increased its billing and raised the bar on quality for its job pool by using ORALscreen(TM) in its employee candidate pre-qualifying program. Recently, Staffing Resources successfully integrated use of ORALscreen, the rapid, on- demand, drugs-of-abuse test in its comprehensive screening of temporary and full time job seekers.

"Staffing Resources, Inc. recognized that ORALscreen would offer a tangible, measurable business value. It's very satisfying when Avitar's clients report back that their own business has excelled by using our ORALscreen product," said Peter Phildius, CEO and Chairman of Avitar, Inc.

"ORALscreen matched our need for an on-site drug-testing solution," said George Gorman, General Manager of Staffing Resources, Inc. "As a service provider, Staffing Resources helps other businesses increase productivity and reduce expenses by offering them skilled, screened and ready-to-work temporary employees. ORALscreen helps prevent unwanted drug abusers from entering our job pool, which enhances our service value and differentiates us from other employment providers."

Avitar's ORALscreen is the world's first oral fluid point-of-collection drugs-of-abuse system for detecting marijuana (THC), cocaine, opiates, methamphetamine and Ecstasy. ORALscreen is a highly sensitive, yet simple-to- use, reliable portable drug test that detects the presence of specific illegal substances within minutes. While urine testing requires the off-premises, humiliating collection of adulterable samples, with ORALscreen, oral fluid is collected under readily observable conditions, on-site and on-demand, making it nearly impossible to contaminate test results.

ORALscreen provides an optimum solution for the substance abuse testing needs of the ever-expanding staffing industry. According to the American Staffing Association (ASA), the temporary staffing industry represents $75 billion. In July, the ASA reported staffing firms employed 2.88 million temporary workers on an average day in the first three months of this year.

Staffing Resources, Inc. attracts and retains a talent pool for three divisions of skilled employees: clerical/accounting, office automation and industrial labor. While the broad range of job assignments varies from typists to stenographers, accountants to word-processors, fork lift drivers to material handlers, Staffing Resources stands behind its staffing pool and guarantees a high level of training, professionalism, and onsite productivity because of its use of thorough testing. Since 1993 the owners of Staffing Resources, Inc. have specialized in helping companies find new ways to increase profitability through planned supplemental staffing. Staffing Resources was ranked #185 in the 1998 Inc. 500 class list of America's fastest growing private companies recognized for growth contributing to the U.S. economy.

Avitar, Inc. (Amex: AVR) headquartered in Canton, Massachusetts, develops, manufactures and markets innovative medical devices based on core technologies in oral fluid diagnostics and customized polyurethane applications. The company markets a unique portfolio of substance abuse testing products and services that include ORALscreen(TM), the world's first rapid point-of- collection oral fluid test for drugs of abuse, ORALadvantage(TM), the first comprehensive substance abuse program featuring its oral fluid-based products, HAIRscreen(TM), a laboratory-based test for detecting long term drug abuse using hair, and several other specialized tests for drugs of abuse. ORALscreen is a cost-effective drugs-of-abuse test with potential net cost savings of more than $100.00 per sample tested. Additional products include an oral fluid collection system for DNA testing as well as a proprietary line of polyurethane-based high tech medical devices.

For more information, see Avitar's website at www.avitarinc.com.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext